Insights on the Ophthalmology Global Market to 2027 - Featuring ClearSight, Essex Bio and Sensimed Among Others -

·3-min read

DUBLIN, January 14, 2022--(BUSINESS WIRE)--The "Ophthalmology Market Research Report by Diseases, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to's offering.

The Global Ophthalmology Market size was estimated at USD 52.07 billion in 2020, is expected to reach USD 55.28 billion in 2021, and is projected to grow at a CAGR of 6.52% to reach USD 81.05 billion by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ophthalmology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Ophthalmology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Ophthalmology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Ophthalmology Market?

4. What is the competitive strategic window for opportunities in the Global Ophthalmology Market?

5. What are the technology trends and regulatory frameworks in the Global Ophthalmology Market?

6. What is the market share of the leading vendors in the Global Ophthalmology Market?

7. What modes and strategic moves are considered suitable for entering the Global Ophthalmology Market?

Market Dynamics


  • Increasing geriatric population globally

  • Availability of well-established healthcare infrastructure

  • Rising eye-care issues attributed to changing lifestyles worldwide


  • High cost of treatment


  • Surge in research and development to provide new treatment

  • Ongoing production of novel therapeutic drugs for treatment of eye diseases


  • Dearth of skilled professionals

Companies Mentioned

  • Alcon

  • Alkeus Pharmaceuticals

  • Bausch + Lomb

  • Carl Zeiss AG

  • ClearSight

  • CooperVision

  • Envisia Therapeutics

  • Essex Bio

  • EssilorLuxottica

  • Eyenovia

  • Gensight Biologics

  • Glaukos Corp

  • Hoya Corporation

  • Iris Pharma

  • Johnson & Johnson Vision

  • Kubota Pharmaceuticals

  • LC Technologies


  • Oraya Therapeutics

  • PanOptica

  • PharmOptima

  • Sensimed

  • ThromboGenics

  • Topcon

  • Topivert

  • Unimed Pharma

  • Vision Medicines

  • VisionCare

  • Wellstat Group

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting